medalphabetМедицинский алфавитMedical alphabet2078-56312949-2807ООО «Альфмед»10.33667/2078-5631-2020-32-8-13medalphabet-1817Research ArticleСтатьиКлиническое значение эхокардиографии у больных с COVID-19: систематический обзорClinical value of echocardiography in patients with COVID-19: a systematic reviewАлёхинМ. Н.AlekhinM. N.

д. м. н., профессор кафедры терапии, кардиологии и функциональной диагностики с курсом нефрологии; заведующий отделением функциональной диагностики

Москва

Moscow

ИвановС. И.IvanovS. I.

клинический аспирант кафедры терапии, кардиологии и функциональной диагностики с курсом нефрологии

Москва

Moscow

СтепановаА. И.StepanovaA. I.

клинический аспирант кафедры терапии, кардиологии и функциональной диагностики с курсом нефрологии

Москва

Moscow

ФГБУ ДПО «Центральная государственная медицинская академия» Управления делами Президента Российской Федерации; ФГБУ «Центральная клиническая больница с поликлиникой» Управления делами Президента Российской ФедерацииРоссияCentral State Medical Academy of the Administrative Department of the President of the Russian Federation; Central Clinical Hospital of the Presidential Administration of the Russian FederationRussian FederationФГБУ ДПО «Центральная государственная медицинская академия» Управления делами Президента Российской ФедерацииРоссияCentral State Medical Academy of the Administrative Department of the President of the Russian FederationRussian Federation202013012021032Современная функциональная диагностика (4)813Copyright © Алёхин М.Н., Иванов С.И., Степанова А.И., 20212021Алёхин М.Н., Иванов С.И., Степанова А.И.Alekhin M.N., Ivanov S.I., Stepanova A.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-alphabet.com/jour/article/view/1817

Систематический обзор посвящен оценке роли эхокардиографии в диагностике возможных сердечно-сосудистых осложнений у пациентов с COVID-19 — новым инфекционным заболеванием, недавно бросившем вызов мировому здравоохранению. Проанализированы результаты крупнейших доступных на текущий момент клинических исследований по заданной тематике из ведущих баз данных медицинской литературы. Представлена актуальная информация о выгодных преимуществах и возможных ограничениях использования эхокардиографии в условиях пандемии высококонтагиозного заболевания.

This systematic review is dedicated to the role of echocardiography in diagnostics of possible cardiovascular complications in patients with COVID-19, the emerging infectious disease that has recently challenged global healthcare. The results of the largest current available clinical studies on the given topic from the leading medical databases were analyzed. Up-to-date data about the beneficial advantages and possible limitations of the use of echocardiography in the highly contagious disease pandemic is provided.

эхокардиографияCOVID-19миокардитсистематический обзорechocardiographyCOVID-19myocarditissystematic reviewReferencesLi B., Yang J., Zhao F., Zhi L., Wang X., Liu L., Bi Z, Zhao Y. Prevalence and impact of cardiovascular metabolic disease on COVID‑19 in China. Clin Res Cardiol. 2020:109(5):531–538. doi: 10.1007/s00392–020–01626–9.Li B., Yang J., Zhao F., Zhi L., Wang X., Liu L., Bi Z, Zhao Y. Prevalence and impact of cardiovascular metabolic disease on COVID‑19 in China. Clin Res Cardiol. 2020:109(5):531–538. doi: 10.1007/s00392–020–01626–9.Skulstad H., Cosyns B., Popescu B. A., et al. COVID‑19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel. Eur Heart J Cardiovasc Imaging. 2020;21(6):592–598. doi: 10.1093/ehjci/jeaa072.Skulstad H., Cosyns B., Popescu B. A., et al. COVID‑19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel. Eur Heart J Cardiovasc Imaging. 2020;21(6):592–598. doi: 10.1093/ehjci/jeaa072.Kirkpatrick J. N., Mitchell C., Taub C., Kort S., Hung J., Swaminathan M. ASE Statement on Protection of Patients and Echocardiography Service Providers During the 2019 Novel Coronavirus Outbreak: Endorsed by the American College of Cardiology. J Am Soc Echocardiogr. 2020;33(6):648–653. doi: 10.1016/j.echo.2020.04.001.Kirkpatrick J. N., Mitchell C., Taub C., Kort S., Hung J., Swaminathan M. ASE Statement on Protection of Patients and Echocardiography Service Providers During the 2019 Novel Coronavirus Outbreak: Endorsed by the American College of Cardiology. J Am Soc Echocardiogr. 2020;33(6):648–653. doi: 10.1016/j.echo.2020.04.001.Wahi S., Thomas L., Stanton T, et al. CSANZ Imaging Council Position Statement on Echocardiography Services During the COVID‑19 Pandemic. Heart Lung Circ. 2020;29(6):e78–e83. doi: 10.1016/j.hlc.2020.04.003.Wahi S., Thomas L., Stanton T, et al. CSANZ Imaging Council Position Statement on Echocardiography Services During the COVID‑19 Pandemic. Heart Lung Circ. 2020;29(6):e78–e83. doi: 10.1016/j.hlc.2020.04.003.Sattarzadeh Badkoubeh R., Almassi N., Moshkani Farahani M., et al. The Iranian Society of Echocardiography (ISE) Statement on Performing Echocardiography During the COVID‑19 Pandemic. Curr Probl Cardiol. 2020;45(8):100620. doi: 10.1016/j.cpcardiol.2020.100620.Sattarzadeh Badkoubeh R., Almassi N., Moshkani Farahani M., et al. The Iranian Society of Echocardiography (ISE) Statement on Performing Echocardiography During the COVID‑19 Pandemic. Curr Probl Cardiol. 2020;45(8):100620. doi: 10.1016/j.cpcardiol.2020.100620.Hu H., Ma F., Wei X., Fang Y. Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur Heart J. 2020; ehaa190. doi: 10.1093/eurheartj/ehaa190.Hu H., Ma F., Wei X., Fang Y. Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur Heart J. 2020; ehaa190. doi: 10.1093/eurheartj/ehaa190.Bangalore S., Sharma M. H. A., Slotwiner A., Yatskar L., Harari R., Shah B., Ibrahim H., Friedman G. H., Thompson C., Alviar C. L., Chadow H. L., Fishman G. I., Reynolds H.R., Keller N., Hochman J. S. ST‑Segment Elevation in Patients with Covid‑19 — A Case Series. N Engl J Med. 2020;382(25):2478–2480. doi: 10.1056/NEJMc2009020.Bangalore S., Sharma M. H. A., Slotwiner A., Yatskar L., Harari R., Shah B., Ibrahim H., Friedman G. H., Thompson C., Alviar C. L., Chadow H. L., Fishman G. I., Reynolds H.R., Keller N., Hochman J. S. ST‑Segment Elevation in Patients with Covid‑19 — A Case Series. N Engl J Med. 2020;382(25):2478–2480. doi: 10.1056/NEJMc2009020.Meyer P., Degrauwe S., Delden C. V., Ghadri J. R., Templin C. Typical takotsubo syndrome triggered by SARS‑CoV‑2 infection. Eur Heart J. 2020;41(19):1860. doi: 10.1093/eurheartj/ehaa306.Meyer P., Degrauwe S., Delden C. V., Ghadri J. R., Templin C. Typical takotsubo syndrome triggered by SARS‑CoV‑2 infection. Eur Heart J. 2020;41(19):1860. doi: 10.1093/eurheartj/ehaa306.Dweck M. R., Bularga A., Hahn R.T, Bing R., Lee K. K., Chapman A. R., White A., Salvo G. D., Sade L. E., Pearce K., Newby D. E., Popescu B. A., Donal E., Cosyns B., Edvardsen T., Mills N. L., Haugaa K. Global evaluation of echocardiography in patients with COVID‑19. Eur Heart J Cardiovasc Imaging. 2020; jeaa178. doi: 10.1093/ehjci/jeaa178.Dweck M. R., Bularga A., Hahn R.T, Bing R., Lee K. K., Chapman A. R., White A., Salvo G. D., Sade L. E., Pearce K., Newby D. E., Popescu B. A., Donal E., Cosyns B., Edvardsen T., Mills N. L., Haugaa K. Global evaluation of echocardiography in patients with COVID‑19. Eur Heart J Cardiovasc Imaging. 2020; jeaa178. doi: 10.1093/ehjci/jeaa178.Churchill T. W., Bertrand P. B., Bernard S., Namasivayam M., Churchill J., Crousillat D., Davis E. F., Hung J., Picard M. H. Echocardiographic Features of COVID‑19 Illness and Association with Cardiac Biomarkers. J Am Soc Echocardiogr. 2020; S0894–7317 (20) 30335–7. doi: 10.1016/j.echo.2020.05.028.Churchill T. W., Bertrand P. B., Bernard S., Namasivayam M., Churchill J., Crousillat D., Davis E. F., Hung J., Picard M. H. Echocardiographic Features of COVID‑19 Illness and Association with Cardiac Biomarkers. J Am Soc Echocardiogr. 2020; S0894–7317 (20) 30335–7. doi: 10.1016/j.echo.2020.05.028.Rath D., Petersen ‑ Uribe Á., Avdiu A., Witzel K., Jaeger P., Zdanyte M., Heinzmann D., Tavlaki E., Müller K., Gawaz M. P. Impaired cardiac function is associated with mortality in patients with acute COVID‑19 infection. Clin Res Cardiol. 2020;1–9. doi: 10.1007/s00392–020–01683–0.Rath D., Petersen ‑ Uribe Á., Avdiu A., Witzel K., Jaeger P., Zdanyte M., Heinzmann D., Tavlaki E., Müller K., Gawaz M. P. Impaired cardiac function is associated with mortality in patients with acute COVID‑19 infection. Clin Res Cardiol. 2020;1–9. doi: 10.1007/s00392–020–01683–0.Mahmoud ‑ Elsayed H. M., Moody W. E., Bradlow W. M., Khan ‑ Kheil A. M., Senior J., Hudsmith L. E., Steeds R. P. Echocardiographic Findings in Patients With COVID‑19 Pneumonia. Can J Cardiol. 2020; S0828–282X(20)30509–2. doi: 10.1016/j.cjca.2020.05.030.Mahmoud ‑ Elsayed H. M., Moody W. E., Bradlow W. M., Khan ‑ Kheil A. M., Senior J., Hudsmith L. E., Steeds R. P. Echocardiographic Findings in Patients With COVID‑19 Pneumonia. Can J Cardiol. 2020; S0828–282X(20)30509–2. doi: 10.1016/j.cjca.2020.05.030.Li Y., Li H., Zhu S., Xie Y., Wang B., He L., Zhang D., Zhang Y., Yuan H., Wu C., Sun W., Zhang Y., Li M., Cui L., Cai Y., Wang J., Yang Y., Lv Q., Zhang L., Xie M. Prognostic Value of Right Ventricular Longitudinal Strain in Patients With COVID‑19. JACC Cardiovasc Imaging. 2020; S1936–878X(20)30342–9. doi: 10.1016/j.jcmg.2020.04.014.Li Y., Li H., Zhu S., Xie Y., Wang B., He L., Zhang D., Zhang Y., Yuan H., Wu C., Sun W., Zhang Y., Li M., Cui L., Cai Y., Wang J., Yang Y., Lv Q., Zhang L., Xie M. Prognostic Value of Right Ventricular Longitudinal Strain in Patients With COVID‑19. JACC Cardiovasc Imaging. 2020; S1936–878X(20)30342–9. doi: 10.1016/j.jcmg.2020.04.014.Коган Е. А., Березовский Ю. С., Благова О. В., Куклева А. Д., Богачева Г. А., Курилина Э. В., Калинин Д. В., Багдасарян Т. Р., Семенова Л. А., Грецов Е. М., Эргешов А. Э., Фомин В. В. Миокардит у пациентов с COVID‑19, подтвержденный результатами иммуногистохимического исследования. Кардиология. 2020;60(7):4–10.Kogan E. A., Berezovskiy Yu.S., Blagova O. V., Kukleva A. D., Bogacheva G. A., Kurilina E. V., Kalinin D. V., Bagdasaryan T. R., Semyonova L. A., Gretsov E. M., Ergeshov A. E., Fomin V. V. Miocarditis in Patients with COVID‑19 Confirmed by Immunohistochemical. Kardiologiia. 2020;60(7):4–10. In RussianStefanini G. G., Montorfano M., Trabattoni D., Andreini D., Ferrante G., Ancona M., Metra M., Curello S., Maffeo D., Pero G., Cacucci M., Assanelli E., Bellini B., Russo F., Ielasi A., Tespili M., Danzi G. B., Vandoni P., Bollati M., Barbieri L., Oreglia J., Lettieri C., Cremonesi A., Carugo S., Reimers B., Condorelli G., Chieffo A. ST‑Elevation Myocardial Infarction in Patients With COVID‑19: Clinical and Angiographic Outcomes. Circulation. 2020;141(25):2113–2116. doi: 10.1161/CIRCULATIONAHA.120.047525.Stefanini G. G., Montorfano M., Trabattoni D., Andreini D., Ferrante G., Ancona M., Metra M., Curello S., Maffeo D., Pero G., Cacucci M., Assanelli E., Bellini B., Russo F., Ielasi A., Tespili M., Danzi G. B., Vandoni P., Bollati M., Barbieri L., Oreglia J., Lettieri C., Cremonesi A., Carugo S., Reimers B., Condorelli G., Chieffo A. ST‑Elevation Myocardial Infarction in Patients With COVID‑19: Clinical and Angiographic Outcomes. Circulation. 2020;141(25):2113–2116. doi: 10.1161/CIRCULATIONAHA.120.047525.Irabien‑Ortiz Á., Carreras‑Mora J., Sionis A., Pàmies J., Montiel J., Tauron M. Fulminant myocarditis due to COVID‑19. Rev Esp Cardiol (Engl Ed). 2020;73(6):503–504. doi: 10.1016/j.rec.2020.04.005.Irabien‑Ortiz Á., Carreras‑Mora J., Sionis A., Pàmies J., Montiel J., Tauron M. Fulminant myocarditis due to COVID‑19. Rev Esp Cardiol (Engl Ed). 2020;73(6):503–504. doi: 10.1016/j.rec.2020.04.005.Zeng J. H., Liu Y. X., Yuan J., Wang F. X., Wu W. B., Li J. X., Wang L. F., Gao H., Wang Y., Dong C. F., Li Y. J., Xie X. J., Feng C., Liu L. First case of COVID‑19 complicated with fulminant myocarditis: a case report and insights. Infection. 2020;1–5. doi: 10.1007/s15010‑020‑01424‑5.Zeng J. H., Liu Y. X., Yuan J., Wang F. X., Wu W. B., Li J. X., Wang L. F., Gao H., Wang Y., Dong C. F., Li Y. J., Xie X. J., Feng C., Liu L. First case of COVID‑19 complicated with fulminant myocarditis: a case report and insights. Infection. 2020;1–5. doi: 10.1007/s15010‑020‑01424‑5.Deng Q., Hu B., Zhang Y., Wang H., Zhou X., Hu W., Cheng Y., Yan J., Ping H., Zhou Q. Suspected myocardial injury in patients with COVID‑19: Evidence from front‑line clinical observation in Wuhan, China. Int J Cardiol. 2020;311:116–121 doi: 10.1016/j.ijcard.2020.03.087.Deng Q., Hu B., Zhang Y., Wang H., Zhou X., Hu W., Cheng Y., Yan J., Ping H., Zhou Q. Suspected myocardial injury in patients with COVID‑19: Evidence from front‑line clinical observation in Wuhan, China. Int J Cardiol. 2020;311:116–121 doi: 10.1016/j.ijcard.2020.03.087.Ward R. P., Lee L., Ward T. J., Lang R. M. Utilization and Appropriateness of Transthoracic Echocardiography in Response to the COVID‑19 Pandemic. JAm Soc Echocardiogr. 2020;33(6):690–691. doi: 10.1016/j.echo.2020.04.006.Ward R. P., Lee L., Ward T. J., Lang R. M. Utilization and Appropriateness of Transthoracic Echocardiography in Response to the COVID‑19 Pandemic. JAm Soc Echocardiogr. 2020;33(6):690–691. doi: 10.1016/j.echo.2020.04.006.

The authors declare that there are no conflicts of interest present.